✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Drizalma Sprinkle is a drug marketed by Sun Pharm and is included in one NDA. There are four patents protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in DRIZALMA SPRINKLE is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.
A generic version of DRIZALMA SPRINKLE was approved as duloxetine hydrochloride by AUROBINDO PHARMA LTD on December 11th, 2013.
Summary for DRIZALMA SPRINKLE
Pharmacology for DRIZALMA SPRINKLE
DRIZALMA SPRINKLE is protected by four US patents.
Patents protecting DRIZALMA SPRINKLE
See the table below for patents covering DRIZALMA SPRINKLE around the world.
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|0273658||2005C/001||Belgium||See Plans and Pricing||PRODUCT NAME: CHLORHYDRATE DE DULOXETINE; REGISTRATION NO/DATE: EU/1/04/280/001 20040811|
|0273658||SPC/GB05/003||United Kingdom||See Plans and Pricing||PRODUCT NAME: DULOXETINE AND PHARMACUETICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, AND IN PARTICULAR DULOXETINE HYDROCHLORIDE; REGISTERED: UK EU/1/04/280/001 20040811; UK EU/1/04/280/002 20040811; UK EU/1/04/280/003 20040811; UK EU/1/04/280/004 20040811; UK EU/1/04/280/005 20040811; UK EU/1/04/280/006 20040811|
|0273658||C300171||Netherlands||See Plans and Pricing||PRODUCT NAME: DULOXETINE EN FARMACEUTISCH AANVAARDBARE ZUURADDITIEZOUTEN DAARVAN, EN IN HET BIJZONDER DULOXETINE HYDROCHLORIDE; NATL REGISTRATION NO/DATE: EU/1/04/280/001-006 20040811|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|